Involvement of Peroxisome Proliferator-Activated Receptor-Alpha in Liver Tumor Production by Permethrin in the Female Mouse

Miwa Kondo, Kaori Miyata, Hirohisa Nagahori, Kayo Sumida, Thomas G. Osimitz, Samuel M. Cohen, Brian G. Lake, Tomoya Yamada

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The nongenotoxic pyrethroid insecticide permethrin produced hepatocellular tumors in CD-1 mice but not in Wistar rats. Recently, based on findings of a Pathology Working Group involving an expert panel of pathologists, it was concluded that permethrin increased liver tumors at 2500 and 5000 ppm in female mice, but no treatment-related tumorigenic response occurred in male mice at dose levels examined in the 2-year bioassay. To evaluate a possible mode of action (MOA) for the permethrin female CD-1 mouse hepatocellular tumors, a number of investigative studies were conducted. In time-course studies in female CD-1 mice, permethrin increased relative liver weight and enhanced hepatocyte proliferation within 1 week. Treatment with permethrin resulted in marked increases in CYP4A enzyme activities and mRNA levels, but only slightly increased CYP2B markers, suggesting that permethrin primarily activates the peroxisome proliferator-activated receptor alpha (PPARα) and to a much lesser extent the constitutive androstane receptor. The effects of permethrin on relative liver weight, hepatocyte proliferation and CYP4A enzyme activities and mRNA levels were dose-dependent and were reversible within 5 weeks after cessation of treatment. The hepatic effects of permethrin observed in wild-type female mice were markedly reduced in PPARα knockout female mice. These results demonstrate that the MOA for hepatocellular tumor formation by permethrin in female mice involves activation of PPARα resulting in a mitogenic effect. The MOA for permethrin-induced mouse liver tumor formation due to PPARα activation is considered to be not plausible for humans. This conclusion is strongly supported by available epidemiological data for permethrin.

Original languageEnglish (US)
Pages (from-to)572-596
Number of pages25
JournalToxicological Sciences
Volume168
Issue number2
DOIs
StatePublished - Apr 1 2019

Fingerprint

Permethrin
PPAR alpha
Liver
Tumors
Neoplasms
Cytochrome P-450 CYP4A
Enzyme activity
Hepatocytes
Chemical activation
Weights and Measures
Pyrethrins
Messenger RNA
Time and motion study
Withholding Treatment
Bioassay
Pathology
Enzymes
Insecticides
Knockout Mice
Biological Assay

Keywords

  • cell proliferation
  • mode of action
  • mouse liver tumors
  • nongenotoxic
  • permethrin
  • peroxisome proliferator-activated receptor alpha

ASJC Scopus subject areas

  • Toxicology

Cite this

Involvement of Peroxisome Proliferator-Activated Receptor-Alpha in Liver Tumor Production by Permethrin in the Female Mouse. / Kondo, Miwa; Miyata, Kaori; Nagahori, Hirohisa; Sumida, Kayo; Osimitz, Thomas G.; Cohen, Samuel M.; Lake, Brian G.; Yamada, Tomoya.

In: Toxicological Sciences, Vol. 168, No. 2, 01.04.2019, p. 572-596.

Research output: Contribution to journalArticle

Kondo, Miwa ; Miyata, Kaori ; Nagahori, Hirohisa ; Sumida, Kayo ; Osimitz, Thomas G. ; Cohen, Samuel M. ; Lake, Brian G. ; Yamada, Tomoya. / Involvement of Peroxisome Proliferator-Activated Receptor-Alpha in Liver Tumor Production by Permethrin in the Female Mouse. In: Toxicological Sciences. 2019 ; Vol. 168, No. 2. pp. 572-596.
@article{86baf8204a1944ab9c0677ce9574e7df,
title = "Involvement of Peroxisome Proliferator-Activated Receptor-Alpha in Liver Tumor Production by Permethrin in the Female Mouse",
abstract = "The nongenotoxic pyrethroid insecticide permethrin produced hepatocellular tumors in CD-1 mice but not in Wistar rats. Recently, based on findings of a Pathology Working Group involving an expert panel of pathologists, it was concluded that permethrin increased liver tumors at 2500 and 5000 ppm in female mice, but no treatment-related tumorigenic response occurred in male mice at dose levels examined in the 2-year bioassay. To evaluate a possible mode of action (MOA) for the permethrin female CD-1 mouse hepatocellular tumors, a number of investigative studies were conducted. In time-course studies in female CD-1 mice, permethrin increased relative liver weight and enhanced hepatocyte proliferation within 1 week. Treatment with permethrin resulted in marked increases in CYP4A enzyme activities and mRNA levels, but only slightly increased CYP2B markers, suggesting that permethrin primarily activates the peroxisome proliferator-activated receptor alpha (PPARα) and to a much lesser extent the constitutive androstane receptor. The effects of permethrin on relative liver weight, hepatocyte proliferation and CYP4A enzyme activities and mRNA levels were dose-dependent and were reversible within 5 weeks after cessation of treatment. The hepatic effects of permethrin observed in wild-type female mice were markedly reduced in PPARα knockout female mice. These results demonstrate that the MOA for hepatocellular tumor formation by permethrin in female mice involves activation of PPARα resulting in a mitogenic effect. The MOA for permethrin-induced mouse liver tumor formation due to PPARα activation is considered to be not plausible for humans. This conclusion is strongly supported by available epidemiological data for permethrin.",
keywords = "cell proliferation, mode of action, mouse liver tumors, nongenotoxic, permethrin, peroxisome proliferator-activated receptor alpha",
author = "Miwa Kondo and Kaori Miyata and Hirohisa Nagahori and Kayo Sumida and Osimitz, {Thomas G.} and Cohen, {Samuel M.} and Lake, {Brian G.} and Tomoya Yamada",
year = "2019",
month = "4",
day = "1",
doi = "10.1093/toxsci/kfz012",
language = "English (US)",
volume = "168",
pages = "572--596",
journal = "Toxicological Sciences",
issn = "1096-6080",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Involvement of Peroxisome Proliferator-Activated Receptor-Alpha in Liver Tumor Production by Permethrin in the Female Mouse

AU - Kondo, Miwa

AU - Miyata, Kaori

AU - Nagahori, Hirohisa

AU - Sumida, Kayo

AU - Osimitz, Thomas G.

AU - Cohen, Samuel M.

AU - Lake, Brian G.

AU - Yamada, Tomoya

PY - 2019/4/1

Y1 - 2019/4/1

N2 - The nongenotoxic pyrethroid insecticide permethrin produced hepatocellular tumors in CD-1 mice but not in Wistar rats. Recently, based on findings of a Pathology Working Group involving an expert panel of pathologists, it was concluded that permethrin increased liver tumors at 2500 and 5000 ppm in female mice, but no treatment-related tumorigenic response occurred in male mice at dose levels examined in the 2-year bioassay. To evaluate a possible mode of action (MOA) for the permethrin female CD-1 mouse hepatocellular tumors, a number of investigative studies were conducted. In time-course studies in female CD-1 mice, permethrin increased relative liver weight and enhanced hepatocyte proliferation within 1 week. Treatment with permethrin resulted in marked increases in CYP4A enzyme activities and mRNA levels, but only slightly increased CYP2B markers, suggesting that permethrin primarily activates the peroxisome proliferator-activated receptor alpha (PPARα) and to a much lesser extent the constitutive androstane receptor. The effects of permethrin on relative liver weight, hepatocyte proliferation and CYP4A enzyme activities and mRNA levels were dose-dependent and were reversible within 5 weeks after cessation of treatment. The hepatic effects of permethrin observed in wild-type female mice were markedly reduced in PPARα knockout female mice. These results demonstrate that the MOA for hepatocellular tumor formation by permethrin in female mice involves activation of PPARα resulting in a mitogenic effect. The MOA for permethrin-induced mouse liver tumor formation due to PPARα activation is considered to be not plausible for humans. This conclusion is strongly supported by available epidemiological data for permethrin.

AB - The nongenotoxic pyrethroid insecticide permethrin produced hepatocellular tumors in CD-1 mice but not in Wistar rats. Recently, based on findings of a Pathology Working Group involving an expert panel of pathologists, it was concluded that permethrin increased liver tumors at 2500 and 5000 ppm in female mice, but no treatment-related tumorigenic response occurred in male mice at dose levels examined in the 2-year bioassay. To evaluate a possible mode of action (MOA) for the permethrin female CD-1 mouse hepatocellular tumors, a number of investigative studies were conducted. In time-course studies in female CD-1 mice, permethrin increased relative liver weight and enhanced hepatocyte proliferation within 1 week. Treatment with permethrin resulted in marked increases in CYP4A enzyme activities and mRNA levels, but only slightly increased CYP2B markers, suggesting that permethrin primarily activates the peroxisome proliferator-activated receptor alpha (PPARα) and to a much lesser extent the constitutive androstane receptor. The effects of permethrin on relative liver weight, hepatocyte proliferation and CYP4A enzyme activities and mRNA levels were dose-dependent and were reversible within 5 weeks after cessation of treatment. The hepatic effects of permethrin observed in wild-type female mice were markedly reduced in PPARα knockout female mice. These results demonstrate that the MOA for hepatocellular tumor formation by permethrin in female mice involves activation of PPARα resulting in a mitogenic effect. The MOA for permethrin-induced mouse liver tumor formation due to PPARα activation is considered to be not plausible for humans. This conclusion is strongly supported by available epidemiological data for permethrin.

KW - cell proliferation

KW - mode of action

KW - mouse liver tumors

KW - nongenotoxic

KW - permethrin

KW - peroxisome proliferator-activated receptor alpha

UR - http://www.scopus.com/inward/record.url?scp=85063425601&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063425601&partnerID=8YFLogxK

U2 - 10.1093/toxsci/kfz012

DO - 10.1093/toxsci/kfz012

M3 - Article

C2 - 30629241

AN - SCOPUS:85063425601

VL - 168

SP - 572

EP - 596

JO - Toxicological Sciences

JF - Toxicological Sciences

SN - 1096-6080

IS - 2

ER -